Method for sorting human marrow mesenchymal stemcell by monoclonal antibody ZUF10 immunomagnetic bead
An immunomagnetic bead sorting and bone marrow mesenchymal technology, which is applied in the direction of bone/connective tissue cells, animal cells, vertebrate cells, etc., can solve the problem of complex components of CD45-GlycophorinA- cell populations and the difficulty of direct sorting by immunolabeling Ideal labeling of human bone marrow MSCs, difficulties in the practical application of MSCs separation and purification, etc., to achieve the effect of improving time-consuming, shortening time, and improving efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Separation of primary human bone marrow MSCs by monoclonal antibody ZUF10 immunomagnetic beads
[0023] Bone marrow was collected from a healthy donor, anticoagulated with heparin, and Ficoll-paque (specific gravity 1.077) density gradient centrifugation was used to obtain bone marrow mononuclear cells. Nucleated cells were incubated, centrifuged and washed, then incubated with anti-mouse IgG magnetic bead secondary antibody (Miltenyi Biotec Inc.), centrifuged and washed, isolated from bone marrow mononuclear cells by immunomagnetic bead sorting system to obtain ZUF10 antigen-positive human bone marrow MSCs, Inoculate ZUF10 antigen-positive cells and negative cells on culture dishes respectively, and use low-glucose DMEM medium containing 10% (V / V) fetal bovine serum at 37°C with a volume fraction of 5% CO 2 Culture in an incubator, and then change the medium every 3 days.
[0024] After 3 days of culture, spindle-shaped adherent cells appeared in the culture dish inoc...
Embodiment 2
[0027] Analysis of the proliferation ability of positive cells obtained by forward immuno-sorting using ZUF10 as a marker
[0028] Take the ZUF10 antigen-positive human bone marrow MSCs first and fifth generation cells cultured in vitro, and press 2×10 4 Cells / well density were seeded in 24-well culture plates, cultured for 1, 2, 3, 4, 5, 6, 7, and 8 days, and cell kinetics analysis was performed. The culture has the following common characteristics: After the cells are subcultured, the cells will completely adhere to the wall in about 8 to 10 hours, and the cell shape will become a spindle cell again; the incubation period of the subculture is about 24 to 48 hours; the logarithmic growth period of the subculture is about 4 ~5 days; after the end of the logarithmic growth phase, it enters the plateau phase; there is no significant difference between the growth of the fifth generation and the first generation cells, see figure 2 . Positive cells obtained by forward immune so...
Embodiment 3
[0030] Phenotypic characteristics of positive cells obtained by forward immuno-sorting using ZUF10 as a marker
[0031] The ZUF10 antigen-positive human bone marrow MSCs of the first and fifth passages cultured and passaged in vitro were treated with CD14-FITC, CD29-PE, CD34-PE, CD44-FITC, CD45-FITC, CD105-PE, CD166-PE, HLA-DR-FITC monoclonal antibody was used as a probe, and the expression of MSCs surface molecules was analyzed by flow cytometry. The results showed that CD29, CD44, CD166, and CD105 (SH2) positive markers showed a single peak, and the expressions of hematopoietic cell differentiation antigens CD14, CD34, CD45, and HLA-DR were all negative, see image 3 , image 3 The immunophenotypic analysis of the positive cells obtained after forward immunosorting marked with ZUF10 was expanded to the fifth passage in vitro. The phenotype of positive cells after forward immuno-sorting with ZUF10 is the phenotype of human bone marrow MSCs, and there is no significant diffe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com